Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

USANA Health Sciences stock

USNA
US90328M1071
923145

Price

40.34
Today +/-
+0.85
Today %
+2.26 %
P

USANA Health Sciences stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the USANA Health Sciences stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the USANA Health Sciences stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the USANA Health Sciences stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze USANA Health Sciences's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

USANA Health Sciences Stock Price History

DateUSANA Health Sciences Price
11/15/202440.34 undefined
11/14/202439.44 undefined
11/13/202441.11 undefined
11/12/202440.52 undefined
11/11/202441.29 undefined
11/8/202440.25 undefined
11/7/202440.53 undefined
11/6/202440.33 undefined
11/5/202438.98 undefined
11/4/202437.91 undefined
11/1/202437.29 undefined
10/31/202436.94 undefined
10/30/202436.74 undefined
10/29/202437.30 undefined
10/28/202437.30 undefined
10/25/202436.81 undefined
10/24/202437.81 undefined
10/23/202436.58 undefined
10/22/202434.48 undefined
10/21/202435.05 undefined

USANA Health Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into USANA Health Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by USANA Health Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects USANA Health Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of USANA Health Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into USANA Health Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing USANA Health Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on USANA Health Sciences’s growth potential.

USANA Health Sciences Revenue, EBIT and net profit per share

DateUSANA Health Sciences RevenueUSANA Health Sciences EBITUSANA Health Sciences Net Income
2026e885.89 M undefined0 undefined52.3 M undefined
2025e861.12 M undefined71.6 M undefined48.31 M undefined
2024e866.73 M undefined76.7 M undefined47.63 M undefined
2023921.01 M undefined93.07 M undefined63.79 M undefined
2022998.6 M undefined107.6 M undefined69.4 M undefined
20211.19 B undefined170.2 M undefined116.5 M undefined
20201.13 B undefined176.5 M undefined124.7 M undefined
20191.06 B undefined146.2 M undefined100.5 M undefined
20181.19 B undefined188.4 M undefined126.2 M undefined
20171.05 B undefined132.5 M undefined62.5 M undefined
20161.01 B undefined138.6 M undefined100 M undefined
2015918.5 M undefined141.7 M undefined94.7 M undefined
2014790.5 M undefined116.1 M undefined76.6 M undefined
2013718.2 M undefined116.7 M undefined79 M undefined
2012648.7 M undefined98.2 M undefined66.4 M undefined
2011581.9 M undefined77.3 M undefined24 M undefined
2010517.6 M undefined68.2 M undefined45.7 M undefined
2009436.9 M undefined50.8 M undefined33.6 M undefined
2008429 M undefined48 M undefined29.9 M undefined
2007423.1 M undefined70.7 M undefined45 M undefined
2006365.2 M undefined62.5 M undefined40.4 M undefined
2005315 M undefined60 M undefined38.9 M undefined
2004259 M undefined44.6 M undefined30.8 M undefined

USANA Health Sciences Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.010.020.060.090.130.130.120.110.130.20.260.320.370.420.430.440.520.580.650.720.790.921.011.051.191.061.131.1910.920.870.860.89
-242.86137.5054.3943.186.35-8.21-7.3216.6750.3829.5021.6215.8715.891.421.6318.5812.3811.5310.8010.0316.209.594.0813.56-10.856.984.59-15.85-7.72-5.97-0.582.79
71.4375.0077.1976.1476.1977.6169.9271.0575.1977.5077.6178.1078.0879.2079.2579.5981.6282.6282.1082.1782.1582.5782.0182.8183.1082.3681.5781.6280.5680.7885.9186.4184.07
5184467961048681100155201246285335340347422480532590649758825867988873925968804744000
02569522820303840452933452466797694100621261001241166963474852
--150.0020.0050.00-44.44-60.00-300.00150.0050.0026.675.2612.50-35.5613.7936.36-46.67175.0019.70-3.8023.686.38-38.00103.23-20.6324.00-6.45-40.52-8.70-25.402.138.33
42.546.453.353.355.749.939.638.841.342.640.839.437.434.432.330.931.931.129.828.427.426.42524.724.622.821.320.319.319.35000
---------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The USANA Health Sciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the USANA Health Sciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220222023
                                                           
31.12.62.61.42.92.56.71915.110.62712.913.313.727.350.470.8146111.1143.2175.8247.1277.9234.8311.9239.8239.83288.4330.42
010010030050040030000000000000000000000000
00.4000.31.4000000000000000000000000
2.16.46.510.59.910.99.59.114.117.722.222.519.423.925.834.13736.547.245.266.164.862.981.968.990.298.398.3267.161.45
0.3123.12.91.41.933.84.35.56.15.66.46.58.79.111.216.718.119.914.813.616.515.213.717.617.5318.517.49
5.4911.216.5151714.218.836.937.138.355.637.943.64670.196.5118.5209.9174.4229.2255.4323.6376.3318.9415.8355.7355.68374409.36
4.611.61522.821.517.619.518.420.223.223.330.352.156.857.2166.460.861.859.271.288101.3102.892126.5128.4125.6125.57117.8117.49
0000000000000000000000000000020
000000000000000000000000000000
000000000000000125.342.642.142.34138.334.335.231.829.830.830.430.4432.429.92
000000004.35.75.75.75.75.75.717.317.717.918.217.917.416.717.416.816.617.417.717.6717.417.1
0.20.40.10.10.211.71.82.422.93.45.47.48.6-17417.313.119.729.635.340.523.721.514.73938.938.9444.630.51
4.81215.122.921.718.621.220.226.930.931.939.463.269.971.5135138.4134.9139.4159.7179192.8179.1162.1187.6215.6212.6212.62212.2215.01
10.22126.339.436.735.635.43963.86870.295101.1113.5117.5205.1234.9253.4349.3334.1408.2448.2502.7538.4506.5631.4568.3568.31586.2624.38
                                                           
66.87.29.1000000000000000000000000.0200.02
000-0.52.92.42.43.714.211.99.215.65.68.116.451.249.343.854.761.669.771.576.57259.462.55050.0155.665.66
0.65.612.221.710.110.612.814.528.934.535.744.326.324.156.490.2118.8134.8200166.4214.9265.4288.1329.5306.1382.8344.6344.64391.6445.22
00-0.1-0.20-0.1-0.6-0.11.21.50.80.41-0.41.55.45.86.95.82.1-3.8-11.6-1.4-10.4-13.9-3.60.50.46-12.8-13.7
000000000000000000000000000000
6.612.419.330.11312.914.618.144.347.945.760.332.931.874.3146.8173.9185.5260.5230.1280.8325.3363.2391.1351.6441.7395.1395.12434.4497.2
1.24.73.24.24.13.42.62.75.25.1510.28.16.95.86.4879.57.810911.89.912.518.213.513.511110.07
0.51.31.41.81.51.31.23.55.96.78.611.114.315.112.219.116.52125.92834.634.934.340.440.853.350.850.7835.532.71
1.91.12.12.762.83.95.18.9111318.523.532.522.533.535.242.860.572.986.894.595.198.382.896.696.596.5197.375.28
01.5002.87.24.12.90000000000000000000000
00002023.40000000000000000000000.79
3.68.66.78.716.414.713.817.62022.826.639.845.954.540.55959.770.895.9108.7131.4138.4141.2148.6136.1168.1160.8160.79143.8118.85
00007.5862.6000028357000000000000000
00.10.40.60010.80.81.11.400009.89.91010.910.69.85.513.713.410.3127.57.54.14.55
0000000000002.31.21.610.90.91.21.11.21.41.11.318.819.214.314.3314.212.16
00.10.40.67.5873.40.81.11.4030.336.28.610.810.810.912.111.7116.914.814.729.131.221.821.8318.316.71
3.68.77.19.323.922.720.82120.823.92839.876.290.749.169.870.581.7108120.4142.4145.3156163.3165.2199.3182.6182.62162.1135.56
10.221.126.439.436.935.635.439.165.171.873.7100.1109.1122.5123.4216.6244.4267.2368.5350.5423.2470.6519.2554.4516.8641577.7577.74596.5632.76
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of USANA Health Sciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand USANA Health Sciences's financial health and stability.

Assets

USANA Health Sciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that USANA Health Sciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of USANA Health Sciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into USANA Health Sciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199419951996199719981999nullnull20002001200220032004nullnull20052006200720082009null2010nullnull20112012201320142015nullnull201620172018201920202021202220222023
025695952282030203039404529332945334550667976947694100621261001241161166963
00023434444343455567677788981089131616141313131312
0000000001-100000-1-1-2-2-23-23-140-1-2-1-2-3190-3-2-3-2-7-2
01-1-1-30-30-312909011335-1551-15116925102510107-7-80-28-286-27
00001414001111113613186189821177410-40333331393837233439
000000001,0000000000000000000000000000000000
00435454413292915192520222021222124272727352635524670545359594542
034710151015410153538353848615846324666326670929810511110511113712315212616012112110370
0-4-7-5-11-4-11-4-5-6-3-4-7-4-7-4-11-26-16-4-16-4-4-4-10-8-8-20-23-20-23-32-13-11-16-15-12-12-16-14
0-3-7-4-11-4-11-4-2-6-2-9-9-9-9-5-11-26-15-3-15-46-3-46-10-8-21-16-25-16-25-31-12-6947-34-14-14-12-11
00010000200-5-2-5-2-100000-420-4200-134-14-100-5764-18-1-142
0000000000000000000000000000000000000000
001-10100102-3-3-90-9000287-287-7-28-70000000000000000
02001-231-23-20-6-4-33-4-33-46-37-76-39-1-39-5-1-5-33-68-17-127-61-127-61-64-50-105-150-57-177-177-25-11
021-11-111-110-3-9-13-33-13-33-46-33-46-29-29-29-9-29-9-33-64-10-113-49-113-49-64-50-105-152-59-181-181-30-14
00000101000000004120220203714121412000-2-2-3-3-4-3
0000000000000000000000000000000000000000
02-110-10-110412-312-3-416-1400010010262066-2632-26323271-332078-72-724741
0.3-0.3-3.61.8-0.710.100-1.23.412.930.931.20043.750.331.929.928.4061.90059.584.490.884.887.800104.3110.6140.7110.1145.3108.408756.15
0000000000000000000000000000000000000000

USANA Health Sciences stock margins

The USANA Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of USANA Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for USANA Health Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the USANA Health Sciences's sales revenue. A higher gross margin percentage indicates that the USANA Health Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the USANA Health Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the USANA Health Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the USANA Health Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the USANA Health Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the USANA Health Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

USANA Health Sciences Margin History

USANA Health Sciences Gross marginUSANA Health Sciences Profit marginUSANA Health Sciences EBIT marginUSANA Health Sciences Profit margin
2026e80.82 %0 %5.9 %
2025e80.82 %8.32 %5.61 %
2024e80.82 %8.85 %5.5 %
202380.82 %10.11 %6.93 %
202280.58 %10.78 %6.95 %
202181.64 %14.34 %9.82 %
202081.57 %15.56 %10.99 %
201982.33 %13.78 %9.47 %
201883.12 %15.84 %10.61 %
201782.87 %12.65 %5.97 %
201682.09 %13.78 %9.94 %
201582.61 %15.43 %10.31 %
201482.19 %14.69 %9.69 %
201382.25 %16.25 %11 %
201282.15 %15.14 %10.24 %
201182.52 %13.28 %4.12 %
201081.57 %13.18 %8.83 %
200979.45 %11.63 %7.69 %
200879.28 %11.19 %6.97 %
200779.25 %16.71 %10.64 %
200678.12 %17.11 %11.06 %
200578.19 %19.05 %12.35 %
200477.72 %17.22 %11.89 %

USANA Health Sciences Stock Sales Revenue, EBIT, Earnings per Share

The USANA Health Sciences earnings per share therefore indicates how much revenue USANA Health Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue USANA Health Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates USANA Health Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of USANA Health Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating USANA Health Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

USANA Health Sciences Revenue, EBIT and net profit per share

DateUSANA Health Sciences Sales per ShareUSANA Health Sciences EBIT per shareUSANA Health Sciences Earnings per Share
2026e46.48 undefined0 undefined2.74 undefined
2025e45.18 undefined0 undefined2.53 undefined
2024e45.47 undefined0 undefined2.5 undefined
202347.61 undefined4.81 undefined3.3 undefined
202251.74 undefined5.58 undefined3.6 undefined
202158.45 undefined8.38 undefined5.74 undefined
202053.27 undefined8.29 undefined5.85 undefined
201946.53 undefined6.41 undefined4.41 undefined
201848.34 undefined7.66 undefined5.13 undefined
201742.4 undefined5.36 undefined2.53 undefined
201640.24 undefined5.54 undefined4 undefined
201534.79 undefined5.37 undefined3.59 undefined
201428.85 undefined4.24 undefined2.8 undefined
201325.29 undefined4.11 undefined2.78 undefined
201221.77 undefined3.3 undefined2.23 undefined
201118.71 undefined2.49 undefined0.77 undefined
201016.23 undefined2.14 undefined1.43 undefined
200914.14 undefined1.64 undefined1.09 undefined
200813.28 undefined1.49 undefined0.93 undefined
200712.3 undefined2.06 undefined1.31 undefined
20069.76 undefined1.67 undefined1.08 undefined
20057.99 undefined1.52 undefined0.99 undefined
20046.35 undefined1.09 undefined0.75 undefined

USANA Health Sciences business model

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide. USANA Health Sciences is one of the most popular companies on Eulerpool.com.

USANA Health Sciences SWOT Analysis

Strengths

1. Strong Brand Reputation: USANA Health Sciences Inc has built a strong reputation in the health and wellness industry, known for its high-quality products and commitment to scientific research.

2. Extensive Product Line: The company offers a wide range of nutritional supplements, personal care products, and healthy food choices, catering to diverse customer needs.

3. Established Presence: With operations in multiple countries, USANA has a global presence, allowing it to tap into different markets and reach a larger customer base.

Weaknesses

1. Dependency on Distributor Network: USANA relies heavily on its network of independent distributors for sales and marketing, making it vulnerable to fluctuations in distributor performance and retention.

2. Intense Competition: The health and wellness market is highly competitive, with numerous established players and new entrants vying for market share. USANA needs to continuously innovate to stay ahead of the competition.

3. Product Pricing: USANA's products are priced at a premium compared to some competitors, limiting their accessibility to price-sensitive customers.

Opportunities

1. Growing Health Consciousness: The increasing consumer focus on health and wellness presents an opportunity for USANA to expand its customer base and market its products to individuals seeking healthier lifestyles.

2. Emerging Markets: USANA can explore and expand into emerging markets where there is a rising demand for health and wellness products, such as Asia and Latin America.

3. E-commerce Expansion: With the growing popularity of online shopping, USANA can invest in enhancing its e-commerce capabilities, allowing customers to conveniently purchase their products online.

Threats

1. Regulatory Challenges: The health and wellness industry is subject to stringent regulations and standards. USANA faces the risk of increased regulatory scrutiny, which could impact its operations and product offerings.

2. Economic Uncertainty: Global economic fluctuations and recessions can affect consumer spending on health products, potentially impacting USANA's revenue and profitability.

3. Negative Public Perception: Any adverse incidents or controversies related to the health and wellness industry can tarnish USANA's brand image and erode consumer trust.

USANA Health Sciences Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

USANA Health Sciences Revenue by Segment

DateAmericas and EuropeAmericas And EuropeAsia PacificAsia Pacific TotalC [N]ChinaCHINAGreater ChinaKOREA, REPUBLIC OFNorth AsiaSouth KoreaSoutheast Asia And PacificSoutheast Asia PacificU [S]
2023180.58 M USD--740.44 M USD-427.27 M USD----95.91 M USD---
2022223.27 M USD-963.19 M USD---506.1 M USD563.47 M USD125.84 M USD129.92 M USD--269.8 M USD-
2022196.69 M USD--801.92 M USD-453.13 M USD----106.39 M USD---
2021219.62 M USD-915.02 M USD---470.18 M USD530.51 M USD-114.96 M USD--269.56 M USD-
2019-208.64 M USD852.27 M USD-471.17 M USD--536 M USD-96.19 M USD-220.09 M USD-105.11 M USD
2018-232.67 M USD956.58 M USD-586.52 M USD--654.39 M USD-76.72 M USD-225.47 M USD-116.3 M USD
2017-236.82 M USD810.44 M USD-482.97 M USD--546.78 M USD-58.38 M USD-205.29 M USD-121.06 M USD
2016-253.64 M USD664.86 M USD-371.74 M USD--441.28 M USD-39.75 M USD-183.83 M USD-141.76 M USD
2016-251.64 M USD754.45 M USD-437.39 M USD--502.3 M USD-46.02 M USD-206.12 M USD-130.43 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

USANA Health Sciences Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

USANA Health Sciences historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

USANA Health Sciences shares outstanding

The number of shares was USANA Health Sciences in 2023 — This indicates how many shares 19.345 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue USANA Health Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates USANA Health Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of USANA Health Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating USANA Health Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

USANA Health Sciences stock splits

In USANA Health Sciences's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for USANA Health Sciences.

USANA Health Sciences latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.49 0.56  (13.2 %)2024 Q3
6/30/20240.66 0.54  (-18.67 %)2024 Q2
3/31/20240.7 0.86  (22.37 %)2024 Q1
12/31/20230.53 0.87  (65.46 %)2023 Q4
9/30/20230.65 0.59  (-9.12 %)2023 Q3
6/30/20230.71 0.89  (25.46 %)2023 Q2
3/31/20230.78 0.95  (21.59 %)2023 Q1
12/31/20220.36 0.66  (83.28 %)2022 Q4
9/30/20220.91 0.78  (-13.98 %)2022 Q3
6/30/20221.16 1  (-13.62 %)2022 Q2
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the USANA Health Sciences stock

Eulerpool World ESG Rating (EESG©)

58/ 100

🌱 Environment

53

👫 Social

69

🏛️ Governance

53

Environment

Scope 1 - Direct Emissions
1,583.78
Scope 2 - Indirect emissions from purchased energy
1,322.67
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
2,906.45
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees58
Percentage of women in management
Percentage of Asian employees52
Share of Asian management55
Percentage of Hispanic/Latino employees11
Hispano/Latino Management share5
Percentage of Black employees1
Black Management Share
Percentage of white employees32
White Management Share39
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

USANA Health Sciences shareholders

%
Name
Stocks
Change
Date
41.36276 % Gull Global, Ltd.7,883,743-102,0003/11/2024
8.48966 % BlackRock Institutional Trust Company, N.A.1,618,129-43,1226/30/2024
8.24793 % The Vanguard Group, Inc.1,572,056-7,7756/30/2024
6.18658 % Renaissance Technologies LLC1,179,163-43,2006/30/2024
5.50687 % Pzena Investment Management, LLC1,049,61072,9779/30/2024
3.58425 % Dimensional Fund Advisors, L.P.683,1583,8896/30/2024
2.45200 % Pacer Advisors, Inc.467,35258,5976/30/2024
2.26853 % State Street Global Advisors (US)432,382-9,4286/30/2024
1.49120 % Geode Capital Management, L.L.C.284,22220,6126/30/2024
1.09618 % Charles Schwab Investment Management, Inc.208,932-29,7746/30/2024
1
2
3
4
5
...
10

USANA Health Sciences Executives and Management Board

Mr. Kevin Guest(60)
USANA Health Sciences Executive Chairman of the Board (since 2004)
Compensation 3.75 M
Mr. Jim Brown(54)
USANA Health Sciences Chief Executive Officer
Compensation 1.79 M
Mr. G. Hekking(53)
USANA Health Sciences Chief Financial Officer
Compensation 1.48 M
Mr. Walter Noot(57)
USANA Health Sciences Chief Operating Officer
Compensation 1.26 M
Mr. David Mulham(62)
USANA Health Sciences Chief Sales Officer
Compensation 1.18 M
1
2
3
4

USANA Health Sciences Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Verint Systems Stock
Verint Systems
SupplierCustomer0,280,82-0,07-0,02-0,450,53
1

Most common questions regarding USANA Health Sciences

What values and corporate philosophy does USANA Health Sciences represent?

USANA Health Sciences Inc represents a dedication to health and well-being through their products and business practices. The company's corporate philosophy centers around their commitment to deeply scientific research and the pursuit of excellence. USANA's values include integrity, innovation, and a focus on people, reflected in their high-quality nutritional supplements and personal care products. With a mission to develop and provide the highest quality science-based health products, USANA Health Sciences Inc aims to empower individuals to take control of their own health and live their best lives.

In which countries and regions is USANA Health Sciences primarily present?

USANA Health Sciences Inc is primarily present in various countries and regions around the world. The multinational company operates in over 20 markets, including the United States, Canada, Mexico, Australia, New Zealand, Hong Kong, Taiwan, South Korea, Japan, Singapore, Malaysia, Thailand, the Netherlands, United Kingdom, France, Belgium, Colombia, Philippines, Germany, Spain, and Italy. With its extensive global presence, USANA Health Sciences Inc caters to a diverse range of customers, providing high-quality nutritional products, personal care items, and weight-management solutions across these regions.

What significant milestones has the company USANA Health Sciences achieved?

USANA Health Sciences Inc has achieved several significant milestones throughout its history. The company has consistently delivered strong financial performance, with a track record of revenue growth and profitability. USANA has received numerous awards and recognition for its exceptional products and business model, including being ranked among the top direct selling companies worldwide. The company has expanded its global presence, successfully entering new markets and establishing a strong international footprint. USANA has also invested in cutting-edge scientific research and development, continuously innovating its product offerings to provide the highest quality nutritional supplements. With a dedicated team and a commitment to health and wellness, USANA Health Sciences Inc continues to thrive in the industry.

What is the history and background of the company USANA Health Sciences?

USANA Health Sciences Inc is a renowned healthcare organization that specializes in manufacturing and distributing nutritional and personal care products. Established in 1992, USANA Health Sciences has grown into a prominent player in the industry. The company's commitment to scientific research and innovative product development has earned it a stellar reputation among health-conscious consumers. USANA Health Sciences has a global presence and operates with a direct-selling business model, allowing individuals to become independent business owners by selling their top-quality products. With a strong emphasis on delivering health and wellness solutions, USANA Health Sciences continues to make a positive impact on people's lives worldwide.

Who are the main competitors of USANA Health Sciences in the market?

The main competitors of USANA Health Sciences Inc in the market include Herbalife Nutrition Ltd, Nu Skin Enterprises Inc, and Shaklee Corporation.

In which industries is USANA Health Sciences primarily active?

USANA Health Sciences Inc is primarily active in the healthcare and wellness industry.

What is the business model of USANA Health Sciences?

USANA Health Sciences Inc operates through a direct selling business model. The company manufactures and distributes science-based nutritional and personal care products. USANA's business model involves independent associates who sell its products directly to customers, earning commissions and bonuses based on their sales and the sales of their team. This model allows USANA to bypass traditional retail channels and establish a strong relationship with its customers. With a focus on health and wellness, USANA Health Sciences Inc aims to provide high-quality products that promote a healthy lifestyle and support optimal well-being.

What is the P/E ratio of USANA Health Sciences 2024?

The USANA Health Sciences P/E ratio is 16.38.

What is the P/S ratio of USANA Health Sciences 2024?

The USANA Health Sciences P/S ratio is 0.9.

What is the Quality Investing of USANA Health Sciences?

The Quality Investing for USANA Health Sciences is 3/10.

What is the revenue of USANA Health Sciences 2024?

The expected USANA Health Sciences revenue is 866.73 M USD.

How high is the profit of USANA Health Sciences 2024?

The expected USANA Health Sciences profit is 47.63 M USD.

What is the business model of USANA Health Sciences

USANA Health Sciences, Inc. is a multinational company specializing in the production and distribution of dietary supplements, personalized health products, and skincare products. It was founded in 1992 and operates in over 20 countries worldwide. USANA operates on a multi-level marketing system, rewarding associates for selling products and recruiting new distributors. The company offers a variety of products including supplements, personalized health products, and skincare products. USANA prides itself on using high-quality ingredients and manufacturing products in safe facilities. They invest in research and development and marketing activities to support business growth and the success of their distributors.

What is the USANA Health Sciences dividend?

USANA Health Sciences pays a dividend of 0 USD distributed over payouts per year.

How often does USANA Health Sciences pay dividends?

The dividend cannot currently be calculated for USANA Health Sciences or the company does not pay out a dividend.

What is the USANA Health Sciences ISIN?

The ISIN of USANA Health Sciences is US90328M1071.

What is the USANA Health Sciences WKN?

The WKN of USANA Health Sciences is 923145.

What is the USANA Health Sciences ticker?

The ticker of USANA Health Sciences is USNA.

How much dividend does USANA Health Sciences pay?

Over the past 12 months, USANA Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, USANA Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of USANA Health Sciences?

The current dividend yield of USANA Health Sciences is .

When does USANA Health Sciences pay dividends?

USANA Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of USANA Health Sciences?

USANA Health Sciences paid dividends every year for the past 0 years.

What is the dividend of USANA Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is USANA Health Sciences located?

USANA Health Sciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von USANA Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of USANA Health Sciences from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did USANA Health Sciences pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of USANA Health Sciences in the year 2023?

In the year 2023, USANA Health Sciences distributed 0 USD as dividends.

In which currency does USANA Health Sciences pay out the dividend?

The dividends of USANA Health Sciences are distributed in USD.

All fundamentals about USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.